Personalized gene-edited immune cell therapy for patients with solid cancers: New data establishes approach for verifying patient-specific cancer mutation targets

SOUTH SAN FRANCISCO, Calif., July 21, 2019 /PRNewswire/ -- PACT Pharma, a leader in the fields of cancer immunology and cell therapy in collaboration with a team at UCLA, presented new data demonstrating for the first time the ability to identify mutation targets unique to each person's...

from PR Newswire: https://ift.tt/2Z2NhQl